Intellectual Property & Science is now known as Clarivate Analytics
...and is no longer part of Thomson Reuters. You can still explore their products on this page.
Newport Premium Overview
Powerful integrated API intelligence with unique analysis
Newport Premium™ is the most advanced system for product targeting and global business development and comes in two versions.
Newport Premium for Generics is created specifically for demanding professionals in generic pharmaceutical companies, Pharma Fine Chemicals and API manufacturers, it can help identify and evaluate new product development and licensing opportunities ahead of the competition for both small molecules and follow-on biologics.
Newport Premium™ (for Innovators) is the most advanced generic competitive intelligence system.
Both systems are used to find sources of active ingredients using unique, validated manufacturing intelligence from our global research network. Newport products are now used by more than 380 companies operating in more than 80 countries around the world.
Newport is optimized for use in the following web browsers, within a Microsoft® Windows 2000 or Windows XP operating system:
- Microsoft Internet Explorer® 6.0 or higher available from the Microsoft website.
- Mozilla Firefox® 2.0 or higher available from the Mozilla website.
Newport is best viewed at a minimum monitor resolution of 1024 by 768 pixels or higher.
Enhance your Cortellis Competitive Intelligence subscription with access to the world’s most comprehensive Broker Research reports.
Combines the same premier information used by the world's leading pharmaceutical companies from products such as Thomson Reuters Pharma and Thomson Reuters Partnering (formerly IDDB). Features daily updates and pipeline information.
Cortellis Regulatory Intelligence, powered by IDRAC, is a comprehensive source for global regulatory information that allows you to increase regulatory compliance and make faster and informed regulatory decisions.